Literature DB >> 18560940

Chemical mutagenesis: a new strategy against the global threat of infectious diseases.

Etienne Richer1, Salman T Qureshi, Silvia M Vidal, Danielle Malo.   

Abstract

The perpetual evolution of drug-resistant microbes, the overwhelming burden of acquired immune suppression due to HIV, the emergence or re-emergence of various pathogens (West Nile virus, pandemic influenza, Creutzfeld-Jacob disease), and increased fears of bioterrorism has drawn a great deal of new attention to infectious diseases. The pathogenesis of infection is characterized by complex interactions of potentially virulent microorganisms with host genetic and acquired factors. Chemical mutagenesis of the mouse genome provides a robust method to unravel this challenging problem. To deepen our understanding of the natural host response to pathogens, our team and others are interrogating the mouse genome to define genes that are crucial to the defense against infectious diseases (pathogen recognition, viral defense, bacterial defense, prion infection). In this review we highlight the current progress of these efforts and propose a toolbox for other groups that are interested in this endeavor.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18560940     DOI: 10.1007/s00335-008-9114-0

Source DB:  PubMed          Journal:  Mamm Genome        ISSN: 0938-8990            Impact factor:   2.957


  62 in total

1.  PanR1, a dominant negative missense allele of the gene encoding TNF-alpha (Tnf), does not impair lymphoid development.

Authors:  Sophie Rutschmann; Kasper Hoebe; Jonathan Zalevsky; Xin Du; Navjiwan Mann; Bassil I Dahiyat; Paul Steed; Bruce Beutler
Journal:  J Immunol       Date:  2006-06-15       Impact factor: 5.422

2.  On observing and analyzing disease versus signals.

Authors:  Rolf Zinkernagel
Journal:  Nat Immunol       Date:  2007-01       Impact factor: 25.606

Review 3.  Genetic analysis of host resistance: Toll-like receptor signaling and immunity at large.

Authors:  Bruce Beutler; Zhengfan Jiang; Philippe Georgel; Karine Crozat; Ben Croker; Sophie Rutschmann; Xin Du; Kasper Hoebe
Journal:  Annu Rev Immunol       Date:  2006       Impact factor: 28.527

4.  Murine natural killer cells limit coxsackievirus B3 replication.

Authors:  E K Godeny; C J Gauntt
Journal:  J Immunol       Date:  1987-08-01       Impact factor: 5.422

5.  Interleukin (IL)-12 and IL-23 are key cytokines for immunity against Salmonella in humans.

Authors:  Calman MacLennan; Claire Fieschi; David A Lammas; Capucine Picard; Susan E Dorman; Ozden Sanal; Jenny M MacLennan; Steven M Holland; Tom H M Ottenhoff; Jean-Laurent Casanova; Dinakantha S Kumararatne
Journal:  J Infect Dis       Date:  2004-10-07       Impact factor: 5.226

6.  Alleles of the NRAMP1 gene are risk factors for pediatric tuberculosis disease.

Authors:  Suneil Malik; Laurent Abel; Heather Tooker; Audrey Poon; Leah Simkin; Manon Girard; Gerald J Adams; Jeffrey R Starke; Kimberly C Smith; Edward A Graviss; James M Musser; Erwin Schurr
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-15       Impact factor: 11.205

7.  ATP-sensitive potassium channels mediate survival during infection in mammals and insects.

Authors:  Ben Croker; Karine Crozat; Michael Berger; Yu Xia; Sosathya Sovath; Lana Schaffer; Ioannis Eleftherianos; Jean-Luc Imler; Bruce Beutler
Journal:  Nat Genet       Date:  2007-11-18       Impact factor: 38.330

8.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene.

Authors:  A Poltorak; X He; I Smirnova; M Y Liu; C Van Huffel; X Du; D Birdwell; E Alejos; M Silva; C Galanos; M Freudenberg; P Ricciardi-Castagnoli; B Layton; B Beutler
Journal:  Science       Date:  1998-12-11       Impact factor: 47.728

Review 9.  The human model: a genetic dissection of immunity to infection in natural conditions.

Authors:  Jean-Laurent Casanova; Laurent Abel
Journal:  Nat Rev Immunol       Date:  2004-01       Impact factor: 53.106

10.  SLC11A1 (formerly NRAMP1) gene polymorphisms and tuberculosis susceptibility: a meta-analysis.

Authors:  H T Li; T T Zhang; Y Q Zhou; Q H Huang; J Huang
Journal:  Int J Tuberc Lung Dis       Date:  2006-01       Impact factor: 2.373

View more
  5 in total

1.  Role for neutrophils in host immune responses and genetic factors that modulate resistance to Salmonella enterica serovar typhimurium in the inbred mouse strain SPRET/Ei.

Authors:  Lien Dejager; Iris Pinheiro; Pieter Bogaert; Liesbeth Huys; Claude Libert
Journal:  Infect Immun       Date:  2010-07-19       Impact factor: 3.441

2.  N-ethyl-N-nitrosourea-induced mutation in ubiquitin-specific peptidase 18 causes hyperactivation of IFN-αß signaling and suppresses STAT4-induced IFN-γ production, resulting in increased susceptibility to Salmonella typhimurium.

Authors:  Etienne Richer; Caitlin Prendergast; Dong-Er Zhang; Salman T Qureshi; Silvia M Vidal; Danielle Malo
Journal:  J Immunol       Date:  2010-08-06       Impact factor: 5.422

3.  ZBTB7B (ThPOK) Is Required for Pathogenesis of Cerebral Malaria and Protection against Pulmonary Tuberculosis.

Authors:  David Langlais; Philippe Gros; James M Kennedy; Anna Georges; Angelia V Bassenden; Silvia M Vidal; Albert M Berghuis; Ichiro Taniuchi; Jacek Majewski; Mark Lathrop; Marcel A Behr
Journal:  Infect Immun       Date:  2020-01-22       Impact factor: 3.441

4.  CCDC88B is a novel regulator of maturation and effector functions of T cells during pathological inflammation.

Authors:  James M Kennedy; Nassima Fodil; Sabrina Torre; Silayuv E Bongfen; Jean-Frédéric Olivier; Vicki Leung; David Langlais; Charles Meunier; Joanne Berghout; Pinky Langat; Jeremy Schwartzentruber; Jacek Majewski; Mark Lathrop; Silvia M Vidal; Philippe Gros
Journal:  J Exp Med       Date:  2014-11-17       Impact factor: 14.307

5.  An ENU-induced splicing mutation reveals a role for Unc93b1 in early immune cell activation following influenza A H1N1 infection.

Authors:  E I Lafferty; A Flaczyk; I Angers; R Homer; E d'Hennezel; D Malo; C A Piccirillo; S M Vidal; S T Qureshi
Journal:  Genes Immun       Date:  2014-05-22       Impact factor: 2.676

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.